Monetary Management Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $809K | Sell |
14,660
-250
| -2% | -$13.5K | 0.19% | 109 |
|
|
2025
Q4 | $731K | Hold |
14,910
| – | – | 0.17% | 116 |
|
|
2025
Q3 | $644K | Hold |
14,910
| – | – | 0.15% | 125 |
|
|
2025
Q2 | $573K | Hold |
14,910
| – | – | 0.14% | 132 |
|
|
2025
Q1 | $578K | Hold |
14,910
| – | – | 0.16% | 130 |
|
|
2024
Q4 | $504K | Hold |
14,910
| – | – | 0.13% | 140 |
|
|
2024
Q3 | $610K | Hold |
14,910
| – | – | 0.16% | 129 |
|
|
2024
Q2 | $574K | Hold |
14,910
| – | – | 0.15% | 127 |
|
|
2024
Q1 | $639K | Buy |
+14,910
| New | +$615K | 0.18% | 122 |
|
|
2022
Q3 | – | Sell |
-9,000
| Closed | -$490K | – | 346 |
|
|
2022
Q2 | $490K | Hold |
9,000
| – | – | 0.15% | 116 |
|
|
2022
Q1 | $490K | Buy |
9,000
+400
| +5% | +$21.7K | 0.13% | 129 |
|
|
2021
Q4 | $474K | Hold |
8,600
| – | – | 0.12% | 131 |
|
|
2021
Q3 | $411K | Buy |
8,600
+4,360
| +103% | +$219K | 0.11% | 139 |
|
|
2021
Q2 | $211K | Buy |
4,240
+2,400
| +130% | +$115K | 0.06% | 172 |
|
|
2021
Q1 | $82K | Hold |
1,840
| – | – | 0.03% | 217 |
|
|
2020
Q4 | $85K | Hold |
1,840
| – | – | 0.03% | 207 |
|
|
2020
Q3 | $87K | Hold |
1,840
| – | – | 0.03% | 194 |
|
|
2020
Q2 | $94K | Hold |
1,840
| – | – | 0.04% | 184 |
|
|
2020
Q1 | $87K | Hold |
1,840
| – | – | 0.04% | 176 |
|
|
2019
Q4 | $108K | Hold |
1,840
| – | – | 0.04% | 192 |
|
|
2019
Q3 | $98K | Buy |
1,840
+1,600
| +667% | +$82.3K | 0.04% | 202 |
|
|
2019
Q2 | $12K | Hold |
240
| – | – | ﹤0.01% | 287 |
|
|
2019
Q1 | $13K | Hold |
240
| – | – | 0.01% | 282 |
|
|
2018
Q4 | $11K | Hold |
240
| – | – | 0.01% | 278 |
|
|
2018
Q3 | $12K | Hold |
240
| – | – | ﹤0.01% | 292 |
|
|
2018
Q2 | $12K | Hold |
240
| – | – | ﹤0.01% | 296 |
|
|
2018
Q1 | $12K | Hold |
240
| – | – | 0.01% | 298 |
|
|
2017
Q4 | $11K | Hold |
240
| – | – | ﹤0.01% | 298 |
|
|
2017
Q3 | $12K | Hold |
240
| – | – | 0.01% | 284 |
|
|
2017
Q2 | $13K | Hold |
240
| – | – | 0.01% | 286 |
|
|
2017
Q1 | $13K | Sell |
240
-560
| -70% | -$28.4K | 0.01% | 283 |
|
|
2016
Q4 | $39K | Hold |
800
| – | – | 0.02% | 238 |
|
|
2016
Q3 | $43K | Hold |
800
| – | – | 0.02% | 230 |
|
|
2016
Q2 | $43K | Buy |
800
+240
| +43% | +$12.6K | 0.02% | 232 |
|
|
2016
Q1 | $28K | Hold |
560
| – | – | 0.01% | 256 |
|
|
2015
Q4 | $28K | Hold |
560
| – | – | 0.01% | 264 |
|
|
2015
Q3 | $27K | Sell |
560
-5,860
| -91% | -$305K | 0.01% | 266 |
|
|
2015
Q2 | $334K | Hold |
6,420
| – | – | 0.15% | 121 |
|
|
2015
Q1 | $370K | Sell |
6,420
-480
| -7% | -$27.5K | 0.16% | 113 |
|
|
2014
Q4 | $369K | Buy |
+6,900
| New | +$386K | 0.16% | 112 |
|
Other funds holding GSK
JEST
Monetary Management Group's GSK Position: Q1 2026 in Review
Monetary Management Group reduced its GSK (GSK) stake by 1.7% in Q1 2026, selling an estimated $13.5K and leaving 14,660 shares worth $809K. The position accounts for 0.19% of the portfolio, ranked #109.
Monetary Management Group first reported a position in GSK in Q4 2014 and has held it in 40 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Monetary Management Group held 14,660 shares of GSK worth $809K as of Q1 2026.
- Monetary Management Group sold 250 GSK shares in Q1 2026, an estimated $13.5K.
- GSK made up 0.19% of Monetary Management Group's portfolio in Q1 2026, its #109 holding.
- Monetary Management Group first reported a position in GSK in Q4 2014 and has held it in 40 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.